[1]
“MAPK/ERK and NF-κB Signaling Pathways Mediate Attenuation of Psoriasis by Punicalagin”, Phytopharmacological Com., vol. 3, no. 2, pp. 77–80, Dec. 2023, doi: 10.55627/ppc.003.02.0471.